Health Marketing Firm Quaintise Provides UCLA’s Institute for Precision Health to the Client Base
Quaintise, a Los Angeles-based marketing and branding agency concentrated in the health and wellness industries, announced they've been selected by UCLA to develop the branding and marketing campaign for the school’s Institute for Precision Health.
“We tend to be proud to partner with UCLA and collaborate with the leadership of the Institute for Precision Health as they continue to reinvent the healthcare industry with their own future large-scale initiatives in hereditary and genomic medicine,” says Raquel Baldelomar, founder and chief executive of Quaintise.
Launched in February 2017, the Institute for Precision Health develops on UCLA’s existing achievements in precision health, supporting multidisciplinary study into hereditary and genomic medicine. Quaintise plans to more support their particular mission by offering strategic brand strategy understanding and creative assets dependent on the 15 years of experience they have within the healthcare industry.
UCLA’s Precision Medication Program develops the necessary processes and infrastructure to bring genomic information in to the clinical realm. It mobilizes and combines genomic data with clinical data for translational study that involves genetics, genomics, patient phenotypes, and biomaterials
Read more to get more information about Healthcare PR Los Angeles
“We tend to be proud to partner with UCLA and collaborate with the leadership of the Institute for Precision Health as they continue to reinvent the healthcare industry with their own future large-scale initiatives in hereditary and genomic medicine,” says Raquel Baldelomar, founder and chief executive of Quaintise.
Launched in February 2017, the Institute for Precision Health develops on UCLA’s existing achievements in precision health, supporting multidisciplinary study into hereditary and genomic medicine. Quaintise plans to more support their particular mission by offering strategic brand strategy understanding and creative assets dependent on the 15 years of experience they have within the healthcare industry.
UCLA’s Precision Medication Program develops the necessary processes and infrastructure to bring genomic information in to the clinical realm. It mobilizes and combines genomic data with clinical data for translational study that involves genetics, genomics, patient phenotypes, and biomaterials
Read more to get more information about Healthcare PR Los Angeles
Replies